Apixaban versus Warfarin in Patients with Atrial Fibrillation
In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality. (Funded...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 8,687
- Institution
- Bristol-Myers Squibb (United States)
External Links
Identifiers
- ORCID
- 0000-0003-0825-4075
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.